Spok Holdings Inc (SPOK)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $244.25M
Last updated: Nov 17, 2026 at 11:06 AM ET
Spok Holdings Inc (SPOK) P/E Ratio & Valuation History
Spok Holdings (SPOK) trades at 13.2x trailing earnings and 1.8x sales. Its P/S of 1.8x is below its 5-year median of 2.0x. Its forward P/E is 10.2x. The median P/E across 4 similar companies is 8.1x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 29.4% higher over the next year. Its free cash flow yield is 12.2%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 13.2x |
| Forward P/E | 10.2x |
| Price to sales | 1.8x |
| Price to book | 1.7x |
| EV/EBITDA | 7.5x |
| Price to FCF | 8.2x |
| EV/FCF | 7.2x |
| PEG | N/A |
| FCF yield | 12.2% |
Historical Medians
Against its 10-year medians, its P/S is 5.9% above 1.7x and its P/B is 54.5% above 1.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.8x | 2.0x | 1.7x |
| P/B | 1.7x | 1.7x | 1.1x |
Valuation History
Over the 5 of the 10 year ends shown that have a P/E, its P/E ranged from 15.8x in 2023 to 163.8x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $13.19 | 17.4x | 2.0x | 1.9x |
| 2024 | $16.05 | 18.9x | 2.4x | 2.1x |
| 2023 | $15.48 | 15.8x | 2.2x | 1.9x |
| 2022 | $8.19 | 163.8x | 1.2x | 1.0x |
| 2021 | $9.33 | N/A | 1.3x | 1.0x |
| 2020 | $11.13 | N/A | 1.4x | 1.1x |
| 2019 | $12.23 | N/A | 1.5x | 0.9x |
| 2018 | $13.26 | N/A | 1.5x | 0.9x |
| 2017 | $15.65 | N/A | 1.8x | 1.1x |
| 2016 | $20.75 | 30.5x | 2.4x | 1.3x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SPOK
What is SPOK's forward P/E ratio?
Spok Holdings has a forward P/E ratio of 10.2x.
Is SPOK stock overvalued?
GNG's valuation label for SPOK is Undervalued. Its P/E of 13.2x compares with a median of 8.1x across 4 similar companies.
What is SPOK's price to sales ratio?
Spok Holdings has a price to sales ratio of 1.8x.
SPOK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts